Monographs on alternative therapies: Saint John's wort

Hospital Pharmacy

Volumn 32, Issue 12, 1997, Pages 1621-1632

  Chavez, Mary L ^a   Chavez, Pedro I ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HYPERICIN; HYPERICUM EXTRACT;

ANTINEOPLASTIC ACTIVITY; CANCER; DEPRESSION; DRUG MECHANISM; DRUG USE; HEMORRHOID; HUMAN; HYPERICUM PERFORATUM; PHOTOSENSITIVITY; PRURITUS; RASH; REVIEW; VIRUS INFECTION; WOUND;

EID: 0031456994     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Reynold JER, ed. Martindale's: The Extra Pharmacopoeia. 3rd ed. London: Royal Pharmaceutical Society; 1996.
2. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St. John's wort for depression: An overview and metaanalysis of randomised clinical trials. BMJ. 1996;313:253-258.
3. Awang DVC. Herbal Medicine: St. John's Wort. CPJ-RPC; 1991, 33-35.
4. Anon. St. John's wort. In: Olin BR, ed. The Lawrence Review of Natural Products. St. Louis, MO: Facts and Comparisons: 1995.
5. Murray MT. The Healing Power of Herbs. 2nd ed. Rocklin, CA: Prima Publishing; 1995.
6. Upton R, ed. Monograph on St. John's wort. (American Herbal Pharmacopoeia and Therapeutic Compendium). Herbal-Gram. 1997;40(5):1-32.
7. Brown DJ, Foster S. Phytotherapy: Herbal medicine meets clinical science (part 2). Amer Pharm. 1997;June:31-46.
8. Araya OS, Ford EJH. An investigation of the type of photosensitization caused by the ingestion of St. John's wort (Hypericum perforatum) by calves. J Comp Path. 1981;91:135-141.
9. Bombardelli E, Morazzoni P. Hypericum perforatum. Fitoterapia. 1995;66:43-68.
10. Duke JA. Handbook of Medicinal Herbs. Boca Raton, Florida: CRC Press; 1985.
11. Maizenbacher P, Kovar KA. Analysis and stability of Hyperici Oleum. Planta Med. 1992;58(4):351-354.
12. Anon. A better treatment for depression? University of California at Berkeley Wellness Letter. 1997;13(12):1-2.
13. Bloomfield HH, Nordfors M, McWilliams P. Hypericum and Depression. Los Angeles, CA: Prelude Press; 1996.
14. Bratman S. Beat Depression with St. John's Wort. Rocklin, CA: Prima Publishing; 1997.
15. Hawken CM. St. John's Wort. Pleasant Grove, UT: Woodland Publishing; 1997.
16. Nash M. Nature's prozac? Time. 1997; Sept. 22:80-81.
17. Carper J. Miracle Cures. New York, NY: Harper Collins Publisher; 1997.
18. Suzuki O, Katsumata Y, Oya M, Bladt S, Wagner H. Inhibition of monoamine oxidase by hypericin. Planta Med. 1984; 50:272-274.
19. Bladt S, Wagner H. Inhibition of MAO by fractions and constituents of Hypericum extract. J Geriatr Psychiatry Neurol. 1994; 7:(suppl 1):S57-S59.
20. Holzl J, Demisch L, Gollnik B. Investigations about antidepressive and mood changing effects of Hypericum perforatum. [abstract]. Planta Med. 1989;55:643.
21. Thiele HM, Walper A. Inhibition of MAO and COMT by Hypericum extracts and hypericin. J Geriatr Psychiatry Neurol. 1994;7:(suppl 1):S54-S56.
22. Demisch L, Holzl J, Gollnik B, Kaczmarczyk P. Identification of selective MAO type-A inhibitiors in Hypericum perforatum L (Hyperforat). Pharmacopsychiatry. 1989; 22:194.
23. Lavie G, Mazur Y, Lavie D, Meruelo D. The chemical and biological properties of hypericin: A compound with a broad spectrum of biological activities. Med Research Rev. 1995;15(2):111-119.
24. Cott J. Medicinal plants and dietary supplements: Sources for innovative treatments or adjuncts? Psychopharm Bul. 1995; 31(1):131-137.
25. Perovic S, Muller WEG. Pharmacological profile of Hypericum extract: Effect on serotonin uptake by postsynaptic receptors. Arzneim-Forsch/Drug Research. 45(2):1145-1148.
26. Thiele B, Brink I, Ploch M. Modulation of cytokine expression by Hypericum extract. J Geriatr Psychiatry Neurol. 1994;7(suppl 1):S60-S62.
27. Lavie G, Valentine, F. Levin B, Mazur Y, Gallo G, Lavie D, Weiner D, Meruelo D. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proc Natl Sci USA. 1989;86: 5963-5967.
28. Smith RS. The macrophage theory of depression. Med Hypotheses. 1991;35: 298-306.
29. Hudson JB, Lopez-Bazzocchi I, Towers GHN. Antiviral activities of hypericin. Antiviral Research. 1991:15:101-112.
30. Tang J, Colacino JM, Larsen SH, Spitzer W. Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses. Antiviral Res. 1990;13:313-326.
31. Meruleo D, Lavie G, Lavie D. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: Aro-matic polycyclic diones hypericin and pseudohypericin. Proc Natl Acad Sci USA. 1988;85:5230-5234.
32. Weber ND, Murray BK, North JA, Wood SG. The antiviral agent hypericin has in vitro activity against HSV-1 through non-specific association with viral and cellular membranes. Antiviral Chem. Chemother. 1994; 5(2):83-90.
33. Carpenter S, Kraus GA. Photosensitization is required for inactivation of equine infectious anemia virus by hypericin. Photochem Photobio. 1991;53(2):169-174.
34. Lavie G, Mazur Y, Lavie D, Prince AM, Pascual D, Liebes L. Levin B, Meruelo D. Hypericin as an inactivator of infectious viruses in blood components. Transfusion. 1995;35(5):392-400.
35. VIMRx Pharmaceuticals press release. Blood sterilization technique closer to reality [World Wide Web]. URL:http://www. wimrx.com/05sep95.htm. Oct. 11, 1997.
36. Łopez-Bazzocchi I, Hudson, JB, Tower GHN. Antiviral activity of the photoactive pigment hypericin. Photochem and Photobio. 1991;54(1):95-98.
37. Carpenter S, Fehr MJ, Kraus GA, Petrich JW. Chemiluminescent activation of the antiviral activity of hypericin: A molecular flashlight. Proc Natl Acad Sci USA. 1994; 91:12273-12277.
38. Hudson JB, Harris L, Towers GHN. The importance of light in the anti-HIV effect of hypericin. Antiviral Res. 1993;20: 173-178.
39. Stevenson NR, Lenard J. Antiretroviral activities of hypericin and rose bengal: Photodynamic effect of Friend leukemia virus infection of mice. Antiviral Res. 1993;21:119-127.
40. Thomas C, MacGill RS, Miller GC, Pardini RS. Photoactivation of hypericin generates singlet oxygen in mitochondria and inhibits succinoxidase. Photochem Photobio. 1992;55(1):47-53.
41. Khosa RL, Bhatia N. Anti-fungal effect of Hypericum perforatum. J Sci Res Plants Med. 1982;3:49-50.
42. Takahashi I, Nakanishi S, Kobayashi E, Nakano H, Suzuki K, Tamaoki T. Hypericin and pseudohypericin specifically inhibit protein kinase C: Possible relation to their antiretroviral activity. Biochem Biophys Res Commun. 1989;165(3):1207-1212.
43. Zhang W, Anker L, Law RE, Hinton DR, Gopalakrishna R, Pu Q, Gundimeda U, Weiss MH, Couldwell WT. Enhancement of radiosensitivity in human malignant glioma cells by hypericin in vitro. Clin Cancer Res. 1996;2(5):843-846.
44. Kerb R, Brockmoller J, Staffeldt B. Ploch M, Roots I. Single-dose and steady-state pharmacokinetics of hypericin and pseudo-hypericin. Antimicrob Agents Chemother. 1996;40(9):2087-2093.
45. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association; 1994.
46. Martinez B, Kasper S, Ruhrmann S, Moller HJ. Hypericum in the treatment of seasonal affective disorder. J Geriatr Psychiartry Neurol. 1994;7(suppl 1):S29-S33.
47. Information from AIDS Drugs Hotline: 1-800-TRIALSA. Oct. 10, 1997. [Q10]
48. Vonsover A, Steinbeck KA, Rudich C, Mazur Y, Lavie D, Mandel M, Lavie G. HIV-1 virus load in the serum of AIDS patients undergoing long term therapy with hypericin. Int Conf AIDS. 1996;11:1,120 (Abstract No. Mo.B.1377).
49. Pitisuttihum P, Miagasena S, Suntharasamai P, Sutthan R, Perathamanond P, Wasi C, Shikan U, Peeters P, Tobia AJ. Hypericin: Safety and antiretroviral activity in Thai HIV-positive volunteers. Int Conf AIDS. 1996;11:1,285 (Abstract No.Tu.B.2121).
50. VIMRx reports clinical trial results for VIMRxyn for AIDS [World Wide Web]. URL:http://www.vimrx.com/ 19sep96. Oct. 11, 1997.
51. VIMRx elaborates on clinical trial results for AIDS [World Wide Web]. URL:http://www.vimrx.com/ 23sep96. Oct. 11, 1997.
52. VIMRx pharmaceuticals press release. VIMRx get approval to begin Phase I cancer trial; multi-faceted VIMRxyn drug now in clinical for cancer and AIDS [World Wide Web]. URL:http://www.wimrx. com/ 08aug96. htm. Oct. 11, 1997
53. Tyler V. Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York, NY: Pharmaceutical Products Press; 1993.
54. Golsch S. Vocks E, Rakoski J, Brochow K, Ring J. Reversible increase in photosensitivity to UV-B caused by St. John's wort extract. Hautarzt. 1997;48(4):249-252.
55. Ernst E. St. John's wort, an anti-depressant? A systematic, criteria-based review. Phytomed. 1995;2(1):67-71.
56. Woelk H, Burkard G, Grunwald J. Benefits and risks of the hypericum extract LI 160; drug monitoring study with 3250 patients. J Geriatr Psychiarty Neurol. 1994 7:(suppl 1): S34-S38.
57. Vukovic-Gacic B, Simic D. Identification of natural antimutagens with modulating effects on DNA repair. Basic Life Sci. 1993;61:269-277.
58. DeSmet PAGM. St. John's wort as an anti-depressant [editorial]. BMJ. 1996;313:241-242.
59. NIH issues statement of Hypericum. [World Wide Web]. URL:http:// altmed. od.nih.gov/oam/cam/1997/july/3.htm. October 11, 1997.
60. Ritter J. Red hot remedy: Antidepressant claims hike St. John's wort sales. Chicago Sun-Times. October 15, 1997; p. 60.
61. Nightingale SJ. New safely measures are proposed for dietary supplements containing ephedrine alkaloids. JAMA. 1997; 278(1):15.